Growth in Industrial Business Sales and Varying Performance by Product
First written in FY2017-Q1. 14 of 36 entries say "Advanced", first in FY2017-Q2. Latest entry: 2026-10-09.
Furuno Electric moved to the "Worse" side of this theme in 2017.
0 other companies' latest entry also says "Advanced".
- 2026-10-09AdvancedEarnings
「この結果、産業用事業の売上高は93億４千２百万円(前年同期比34.3％増)となりました。セグメント利益は、８億２千２百万円(前年同期比339.8％増)となりました。」
産業用事業は売上高・セグメント利益とも前年同期を上回り、前年度通期で確認された成長が中間期にも進展した。 - FY2027-H1AdvancedAnnual report
「As a result, revenue in the industrial business was ¥9.342 billion, up 34.3% year on year. Segment profit was ¥822 million, up 339.8% year on year.」
The industrial business posted substantial increases in both revenue and profit, driven by higher sales and production of time-synchronization products, vehicle-mounted ETC units and defense equipment. - 2026-10-06Advancedfinance.yahoo.co.jp
「In the financial results for the first quarter of the fiscal year ending February 2027, the company posted net sales of ¥38.115 billion and operating profit of ¥5.681 billion, while its forecasts as of 10/6 remained unchanged.」
Growth in defense equipment was reported as a factor contributing to results for the first quarter of the fiscal year ending February 2027. - 2026-07-10AdvancedEarnings
「As a result, revenue in the industrial business was ¥4,637 million, up 51.8% year on year. Segment profit was ¥264 million, compared with a loss of ¥52 million in the same period of the previous year.」
The industrial business posted a significant increase in revenue and turned profitable from a loss in the same period of the previous year. - FY2026AdvancedAnnual report
「As a result, revenue from the industrial business was ¥15.821 billion, up 11.3% year on year. Segment profit was ¥782 million, up 57.8% year on year.」
The industrial business posted higher revenue and profit, driven by overseas sales of time-synchronization products and higher production output in the defense equipment business, among other factors. - 2026-04-09AdvancedEarnings
「As a result, revenue in the industrial business was ¥15,821 million, up 11.3% year on year. Segment profit was ¥782 million, up 57.8% year on year.」
The industrial business posted higher revenue and profit for the full year, improving from the decline in profit in the previous interim period. - FY2026-H1WorsenedAnnual report
「As a result, revenue from the industrial business was ¥6.958 billion, up 0.1% year on year. Segment profit was ¥187 million, down 37.6% year on year.」
Revenue from the industrial business was nearly flat, while segment profit declined 37.6% year on year. - FY2025-H1AdvancedAnnual report
「As a result, revenue from the industrial business was ¥6.95 billion, up 15.3% year on year. Segment profit was ¥299 million, up 587.9% year on year.」
The industrial business continued to post higher revenue and profit, with the increase in segment profit reaching 587.9%. Higher sales of time-synchronization products for mobile base stations, OEM contract-manufactured products, biochemical analyzers and defense equipment were cited. - FY2025-Q1AdvancedAnnual report
「As a result, revenue from the industrial business was ¥3.245 billion, up 17.1% year on year. Segment profit was ¥59 million, compared with a loss of ¥142 million in the previous fiscal year.」
Revenue from the industrial business increased 17.1%, and it turned from a loss of ¥142 million in the previous fiscal year to a profit of ¥59 million. Higher sales of time-synchronization products, OEM contract-manufactured products, biochemical analyzers and defense equipment were cited. - FY2024AdvancedAnnual report
「As a result, revenue from the industrial business was ¥12.811 billion, up 15.4% year on year. Segment profit was ¥243 million, up 90.2% year on year.」
For the full fiscal year, revenue from the industrial business increased 15.4% and segment profit rose 90.2%, supported by higher sales of ETC onboard units, GNSS time-synchronization products, healthcare products and defense equipment. - FY2024-Q3AdvancedAnnual report
「Revenue increased mainly as sales of ETC onboard units, GNSS time-synchronization products and biochemical analyzers in the healthcare business remained firm, while sales in the defense equipment business also increased significantly. As a result, revenue from the industrial business was ¥9.43 billion, up 23.8% year on year. Segment profit was ¥286 million, compared with a loss of ¥16 million in the previous fiscal year.」
Revenue from the industrial business increased 23.8% on higher sales of ETC onboard units, GNSS time-synchronization products, biochemical analyzers and defense equipment, and the business turned from a loss in the previous fiscal year to a profit of ¥286 million. - FY2024-Q2AdvancedAnnual report
「Revenue increased as sales of ETC onboard units, GNSS time-synchronization products and biochemical analyzers in the healthcare business rose, while sales in the defense equipment business also increased significantly. As a result, revenue from the industrial business was ¥6.027 billion, up 16.9% year on year. Segment profit was ¥43 million, compared with a loss of ¥39 million in the previous fiscal year, due mainly to higher manufacturing costs in the defense equipment business.」
Revenue increased on higher sales of ETC onboard units, GNSS time-synchronization products, biochemical analyzers and defense equipment, and the business turned from a segment loss in the previous fiscal year to a profit. - FY2024-Q1WorsenedAnnual report
「In the industrial business, sales of biochemical analyzers in the healthcare business were sluggish, and sales of OEM contract-manufactured products and GNSS receiver chips and modules also declined. However, revenue increased as sales of ETC onboard units rose alongside the recovery in domestic vehicle sales, and sales in the defense equipment business also increased. As a result, revenue from the industrial business was ¥2.772 billion, up 2.0% year on year. The segment loss was ¥142 million, compared with a profit of ¥32 million in the previous fiscal year, due to higher manufacturing costs in the defense equipment business and higher research and development expenses in the healthcare business.」
Revenue increased due to the recovery in vehicle sales and higher defense equipment sales, but the business shifted from a profit in the previous fiscal year to a segment loss due to higher manufacturing costs and research and development expenses. - FY2023-Q3Revenue Growth and Reduced LossesAnnual report
「Revenue from the industrial business was ¥7.615 billion, up 0.7% year on year. The segment loss was ¥16 million, compared with a loss of ¥170 million in the previous fiscal year.」
Revenue from the industrial business increased 0.7% year on year, and the segment loss narrowed from ¥170 million to ¥16 million. - FY2023-Q2Narrower revenue decline and smaller loss in the industrial businessAnnual report
「As a result, revenue from the industrial business was ¥5.157 billion, down 0.1% year on year. The segment loss was ¥39 million, compared with a loss of ¥138 million in the previous fiscal year.」
Revenue was nearly flat, down 0.1% year on year, while the segment loss narrowed from ¥138 million to ¥39 million. - FY2023-Q1AdvancedAnnual report
「As a result, revenue from the industrial business was ¥2.719 billion, up 16.1% year on year. Segment profit was ¥32 million, compared with a loss of ¥113 million in the previous fiscal year.」
Revenue from the industrial business increased 16.1%, and it turned from a segment loss in the previous fiscal year to a profit of ¥32 million. - FY2022-Q3WorsenedAnnual report
「As a result, revenue from the industrial business was ¥7.564 billion, down 3.4% year on year. The segment loss was ¥170 million, compared with a profit of ¥279 million in the previous fiscal year.」
Sales of ETC onboard units, GNSS timing products and some healthcare products increased, but revenue declined due to lower sales in the other businesses, and the business shifted from a profit in the previous fiscal year to a segment loss. - FY2022-Q2Return to revenue growth; loss continuedAnnual report
「As a result, revenue from the industrial business was ¥5.16 billion, up 4.9% year on year. The segment loss was ¥138 million, compared with a profit of ¥102 million in the previous fiscal year, due mainly to higher research and development expenses in the healthcare business.」
The industrial business returned to revenue growth, up 4.9% year on year, but shifted from a profit in the previous fiscal year to a loss of ¥138 million due mainly to higher research and development expenses in the healthcare business. - FY2022-Q1WorsenedAnnual report
「As a result, revenue from the industrial business was ¥2.342 billion, down 3.6% year on year. The segment loss was ¥113 million, compared with a profit of ¥56 million in the previous fiscal year, due to lower margins resulting from changes in the revenue mix and other factors.」
The industrial business shifted from higher revenue and a profit in the previous fiscal year to lower revenue and a segment loss. Although sales of ETC onboard units and GNSS timing products increased, sales of biochemical automated analyzers and OEM contract-manufactured products declined, and margins fell due to changes in the revenue mix. - FY2021AdvancedAnnual report
「Profitability improved as inventory-related costs incurred in the previous fiscal year fell away and progress was made in transforming the business structure to expand proprietary-brand products, mainly in the healthcare field. As a result, revenue from the industrial business was ¥10.811 billion, down 6.7% year on year. Segment profit was ¥320 million, compared with a segment loss of ¥284 million in the previous fiscal year.」
Revenue declined 6.7%, but the business turned from a segment loss to a profit of ¥320 million as inventory-related costs fell away and the healthcare business underwent structural transformation. - FY2021-Q3Continued revenue and earnings decline; narrower earnings declineAnnual report
「In the industrial business, sales of biochemical automated analyzers in the healthcare business remained firm. For ETC onboard units in the PNT business, the decline in revenue narrowed as restrictions on long-distance travel were eased, among other factors. As a result, revenue from the industrial business was ¥7.83 billion, down 10.5% year on year. Segment profit declined to ¥279 million, down 20.5% year on year, due to the impact of lower revenue.」
Although biochemical automated analyzers remained firm and the decline in ETC onboard unit revenue narrowed, the industrial business continued to post lower revenue and profit. The rates of decline in revenue and profit both narrowed from the previous quarter. - FY2021-Q2Continued revenue and earnings decline; narrower earnings declineAnnual report
「In the industrial business, sales of biochemical automated analyzers in the healthcare business remained firm. Revenue from ETC onboard units in the PNT business declined, mainly due to the impact of calls to refrain from long-distance travel during the first quarter of the fiscal year. As a result, revenue from the industrial business was ¥4.92 billion, down 15.0% year on year. Segment profit declined to ¥120 million, down 37.9% year on year, due to the impact of lower revenue.」
Although biochemical automated analyzers remained firm, lower ETC onboard unit revenue resulted in continued declines in revenue and profit. The decline in revenue widened from 13.0% in the first quarter to 15.0%, while the decline in profit narrowed from 60.7% to 37.9%. - FY2021-Q1WorsenedAnnual report
「In the industrial business, sales of biochemical automated analyzers in the healthcare business remained relatively firm, while revenue from ETC onboard units in the PNT business declined in line with the drop in new vehicle sales. As a result, revenue from the industrial business was ¥2.43 billion, down 13.0% year on year. The company worked to reduce selling, general and administrative expenses, among other measures, but segment profit declined to ¥56 million, down 60.7% year on year, due to the impact of lower revenue.」
Although biochemical automated analyzers remained relatively firm, the industrial business posted lower revenue and profit due to the decline in ETC onboard unit revenue. - FY2020-Q3Continued revenue and earnings decline; narrower earnings declineAnnual report
「In the Industrial Business, revenue from in-vehicle ETC units in the Communications and GNSS Solutions Business increased, while revenue from automated biochemical analyzers in the Healthcare Business declined. As a result, Industrial Business revenue was ¥8,753 million, down 1.3% year on year, and segment profit was ¥351 million, down 27.7%.」
Revenue from ETC onboard units increased, while revenue from biochemical automated analyzers declined. The decline in revenue was 1.3%, unchanged from the previous quarter, while the decline in segment profit narrowed from 58.8% to 27.7%. - FY2020-Q2Lower revenue and profit continued; revenue decline narrowedAnnual report
「In the Industrial Business, revenue from contract services in the Communications and GNSS Solutions Business declined slightly. Revenue from automated biochemical analyzers in the Healthcare Business also declined slightly. As a result, Industrial Business revenue was ¥5,790 million, down 1.3% year on year, and segment profit was ¥165 million, down 58.8%.」
Lower revenue and profit continued due to declines in contract services and automated biochemical analyzers. The revenue decline narrowed from 11.7% in the first quarter to 1.3%, while profit fell 58.8%. - FY2020-Q1WorsenedAnnual report
「In the Industrial Business, revenue from automated biochemical analyzers in the Healthcare Business declined. Revenue from in-vehicle ETC units in the Communications and GNSS Solutions Business increased, while contract services remained strong but recorded a slight decline in revenue. As a result, Industrial Business revenue was ¥2,794 million, down 11.7% year on year, and segment profit was ¥144 million, down 57.5%.」
Although revenue from in-vehicle ETC units increased, revenue from automated biochemical analyzers and contract services declined, and the Industrial Business shifted from higher revenue and profit in the same period of the previous year to lower revenue and profit. - FY2019WorsenedAnnual report
「In the Industrial Business, revenue from automated biochemical analyzers in the Healthcare Business declined sharply, while revenue from contract services and frequency generators in the Communications and GNSS Solutions Business increased. As a result, Industrial Business revenue was ¥11,843 million, down 0.3% year on year, and segment profit was ¥335 million, down 44.0%.」
Despite growth in communications and GNSS-related businesses, the sharp decline in revenue from automated biochemical analyzers resulted in lower full-year revenue and profit for the Industrial Business. - FY2019-Q3WorsenedAnnual report
「In the Industrial Business, revenue from automated biochemical analyzers declined, while revenue from frequency generators and contract services increased. As a result, Industrial Business revenue was ¥8,868 million, up 3.5% year on year, and segment profit was ¥485 million, down 19.2%.」
Revenue increased due to higher sales of frequency generators and contract services, but segment profit fell 19.2% due in part to lower sales of automated biochemical analyzers, resulting in a shift to higher revenue and lower profit. - FY2019-Q2Continued revenue and profit growth, but at a slower rateAnnual report
「As a result, Industrial Business revenue was ¥5,867 million, up 7.1% year on year, and segment profit was ¥402 million, up 132.0%.」
The Industrial Business continued to post higher revenue and profit, but the growth rates narrowed from the 10.5% increase in revenue and 140.1% increase in segment profit in the immediately preceding cumulative first quarter. - FY2019-Q1Higher revenue and profit; mixed performance by product continuedAnnual report
「As a result, Industrial Business revenue was ¥3,166 million, up 10.5% year on year, and segment profit was ¥340 million, up 140.1%.」
The Industrial Business shifted to higher revenue and higher profit, while large automated biochemical analyzers and in-vehicle ETC units recorded lower revenue, so mixed performance by product continued. - FY2018-Q3WorsenedAnnual report
「In the Industrial Business, revenue increased for frequency generators, while GPS modules for car navigation systems and bone densitometers remained weak, and revenue from in-vehicle ETC units fell sharply. Revenue from automated biochemical analyzers increased for small and medium-sized models, but declined sharply for large models, resulting in lower revenue for automated biochemical analyzers overall. As a result, Industrial Business revenue was ¥8,572 million, down 20.5% year on year, and segment profit was ¥601 million, down 14.8%.」
Weak performance and revenue declines spread across products, including a sharp decline in in-vehicle ETC units, resulting in lower revenue and lower profit for the Industrial Business. - FY2018-Q2WorsenedAnnual report
「In the Industrial Business, revenue increased for frequency generators, while sales of in-vehicle ETC units, GPS modules for car navigation systems and bone densitometers remained sluggish. Revenue from automated biochemical analyzers increased for small and medium-sized models, but declined sharply for large models, resulting in lower revenue for automated biochemical analyzers overall. As a result, Industrial Business revenue was ¥5,480 million, down 23.1% year on year, and segment profit was ¥173 million, down 60.4%.」
Although some products recorded growth, sluggishness and declines spread across major products, resulting in lower revenue and lower profit for the Industrial Business. - FY2018-Q1WorsenedAnnual report
「In the Industrial Business, revenue increased for in-vehicle ETC units, while frequency generators were at the same level as in the same period of the previous year and GPS modules for car navigation systems remained weak. Revenue from automated biochemical analyzers fell sharply, mainly for large models, and revenue from bone densitometers also declined. As a result, Industrial Business revenue was ¥2,866 million, down 15.9% year on year, and segment profit was ¥141 million, down 54.5%.」
Weak performance and revenue declines were reported for some major products other than in-vehicle ETC units, resulting in lower revenue and lower profit for the Industrial Business. - FY2017-Q3RestatedAnnual report
「In the Industrial Business, revenue increased for in-vehicle ETC units, frequency generators and bone densitometers, among others. Revenue from automated biochemical analyzers increased for small and medium-sized models, but large models remained weak, resulting in lower revenue for automated biochemical analyzers overall. As a result, Industrial Business revenue was ¥10,788 million, up 13.2% year on year, and segment profit was ¥706 million, compared with a segment loss of ¥559 million in the same period of the previous year.」
Strong performance in products such as in-vehicle ETC units and mixed performance by model for automated biochemical analyzers continued, while the Industrial Business maintained revenue growth and profitability. - FY2017-Q2AdvancedAnnual report
「In the Industrial Business, revenue increased for in-vehicle ETC units, frequency generators and bone densitometers, among others, but GPS modules for car navigation systems remained weak. Revenue from automated biochemical analyzers increased for small and medium-sized models but declined for large models, resulting in lower revenue for automated biochemical analyzers overall. As a result, Industrial Business revenue was ¥7,122 million, up 22.0% year on year, and segment profit was ¥438 million, compared with a segment loss of ¥735 million in the same period of the previous year.」
Performance continued to vary by product, but Industrial Business revenue increased 22.0% and the segment moved from a loss to a profit. - FY2017-Q1First statedAnnual report
「In the Industrial Business, revenue increased for products including automated biochemical analyzers, bone densitometers, in-vehicle ETC units and frequency generators, but GPS modules for car navigation systems remained weak.」
The Industrial Business recorded revenue growth for multiple products, while GPS modules remained weak.